发热性中性粒细胞减少症的管理：ESMO临床实践指南 - Suppr

Suppr

超能文献

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

作者信息

Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J

机构信息

Institut Jules Bordet-Centre des Tumeurs de l'ULB, Brussels, Belgium.

St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK.

出版信息

Ann Oncol. 2016 Sep;27(suppl 5):v111-v118. doi: 10.1093/annonc/mdw325.

DOI:10.1093/annonc/mdw325

PMID:27664247

Abstract

摘要

相似文献

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.发热性中性粒细胞减少症的管理：ESMO临床实践指南

Ann Oncol. 2016 Sep;27(suppl 5):v111-v118. doi: 10.1093/annonc/mdw325.

Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancer.70岁及以上老年女性早期乳腺癌接受辅助化疗时的发热性中性粒细胞减少症与化疗中断

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):692-6. doi: 10.1016/j.clon.2014.05.002. Epub 2014 Jun 6.

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.辅助化疗（CT）和放疗（RT）在未完全切除（R1）的早期非小细胞肺癌（NSCLC）中的应用：欧洲医学肿瘤学会（ESMO）青年肿瘤学家委员会进行的一项欧洲调查。

Lung Cancer. 2014 Jul;85(1):74-80. doi: 10.1016/j.lungcan.2014.03.010. Epub 2014 Mar 16.

Cefepime and amikacin as empirical therapy in patients with febrile neutropaenia: a single-centre phase II prospective survey.头孢吡肟与阿米卡星作为发热性中性粒细胞减少症患者的经验性治疗：一项单中心II期前瞻性调查

Acta Clin Belg. 2009 Jan-Feb;64(1):35-41. doi: 10.1179/acb.2009.007.

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.接受培非格司亭一级预防的乳腺癌患者的发热性中性粒细胞减少症及相关并发症与现行中性粒细胞减少症管理方法的比较：综合分析结果

Eur J Cancer. 2009 Mar;45(4):608-17. doi: 10.1016/j.ejca.2008.11.021. Epub 2008 Dec 26.

Febrile neutropaenia in cancer patients.癌症患者的发热性中性粒细胞减少症

West Indian Med J. 2010 Mar;59(2):209-14.

Management of febrile neutropenia: ESMO clinical recommendations.发热性中性粒细胞减少症的管理：ESMO临床建议

Ann Oncol. 2009 May;20 Suppl 4:166-9. doi: 10.1093/annonc/mdp163.

Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.氟喹诺酮类和氟康唑预防用药的血液学患者中性粒细胞减少期间不明原因发热的亚胺培南 3 天治疗：一项前瞻性观察安全性研究。

Eur J Cancer. 2009 Nov;45(16):2810-7. doi: 10.1016/j.ejca.2009.06.025. Epub 2009 Aug 3.

The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task Force.欧洲医学肿瘤学会（ESMO）及其通过中东欧特别工作组开展的活动。

Ann Oncol. 1999;10 Suppl 6:9-13.

Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.在英国多中心共享护理环境中，成功引入并审核了一项针对低危儿童发热性中性粒细胞减少症的降阶梯口服抗生素策略。

Eur J Cancer. 2009 Nov;45(16):2843-9. doi: 10.1016/j.ejca.2009.06.003. Epub 2009 Jul 16.

引用本文的文献

Sepsis detection in hematologic and solid tumor malignancies using quantitative inflammatory biomarker differences in a prospective single center study.在一项前瞻性单中心研究中，利用定量炎症生物标志物差异检测血液系统和实体瘤恶性肿瘤中的脓毒症。

Sci Rep. 2025 Aug 28;15(1):31701. doi: 10.1038/s41598-025-15784-1.

Mortality Risk of Colistin vs. Non-Colistin Use in Cancer Patients with Multidrug-Resistant Gram-Negative Bacterial Infections: Stratified by Resistance Profile and Concomitant Medications.癌症患者多重耐药革兰氏阴性菌感染时使用黏菌素与不使用黏菌素的死亡风险：按耐药谱和合并用药分层

Medicina (Kaunas). 2025 Jul 28;61(8):1361. doi: 10.3390/medicina61081361.

Prognostic Factors for 28-Day Mortality in Pediatric Patients with Acute Leukemia and Candidemia Following Intensive Chemotherapy: A Retrospective Study.急性白血病合并念珠菌血症的儿科患者强化化疗后28天死亡率的预后因素：一项回顾性研究

Hematol Rep. 2025 Jul 30;17(4):38. doi: 10.3390/hematolrep17040038.

Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.抗生素处方指南的全球差异及其对未来降低抗菌药物耐药性的影响。

Front Pharmacol. 2025 Aug 7;16:1600787. doi: 10.3389/fphar.2025.1600787. eCollection 2025.

Outcomes and microbiological patterns of bacteremia in chemotherapy-related febrile neutropenia at a tertiary facility in Kenya.肯尼亚一家三级医疗机构中化疗相关发热性中性粒细胞减少症患者菌血症的结局及微生物学特征

IJID Reg. 2025 Jul 18;16:100708. doi: 10.1016/j.ijregi.2025.100708. eCollection 2025 Sep.

Validation of an algorithm for identifying patients with febrile neutropenia: an epidemiological study using real-world data in Japan.一种用于识别发热性中性粒细胞减少症患者的算法的验证：一项使用日本真实世界数据的流行病学研究。

Int J Hematol. 2025 Aug 15. doi: 10.1007/s12185-025-04053-6.

Limited Diagnostic and Therapeutic Value of Chest X-Rays in Hematological Patients With Febrile Neutropenia.胸部X光对血液系统发热性中性粒细胞减少症患者的诊断和治疗价值有限。

Open Forum Infect Dis. 2025 Jul 18;12(8):ofaf419. doi: 10.1093/ofid/ofaf419. eCollection 2025 Aug.

A Puerperal Patient with Leukopenia During Vancomycin Administration: A Case Report and Review of the Literature.1例万古霉素给药期间出现白细胞减少的产后患者：病例报告及文献复习

Int J Mol Sci. 2025 Jul 9;26(14):6584. doi: 10.3390/ijms26146584.

Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML-One Step Closer to Personalized Medicine.微生物与治疗的相互作用：急性髓系白血病中的药物微生物组学——向个性化医疗迈进了一步

Biomedicines. 2025 Jul 18;13(7):1761. doi: 10.3390/biomedicines13071761.

Febrile neutropenia in the Middle East and North Africa Region: trends, management, and outcomes (2000-2024)-A systematic review.中东和北非地区的发热性中性粒细胞减少症：趋势、管理及结局（2000 - 2024年）——一项系统综述

IJID Reg. 2025 Jun 11;16:100682. doi: 10.1016/j.ijregi.2025.100682. eCollection 2025 Sep.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验